Home > Insider Trading > Filing (0001140361-13-034587)

Filing Details

Accession Number:: 0001140361-13-034587
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-08-29 16:35:27
Reporting Period:: 2013-08-27

Filing Date:: 2013-08-29
Accepted Time:: 2013-08-29 16:35:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1311596	Regado Biosciences Inc	RGDO	Pharmaceutical Preparations (2834)	030422069

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1170144	Quaker Bio Ventures Lp	C/O Cira Centre 2929 Arch Street Philadelphia PA 19104		No	No	Yes	No
1223034	Quaker Bioventures Capital Lp	435 Dover Park Drive Bldg 500 Wayne PA 19087		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, Par Value $0.001 Per Share	Acquisiton	2013-08-27	399,201	$0.00	435,129	No	4	C	Direct
Common Stock, Par Value $0.001 Per Share	Acquisiton	2013-08-27	273,468	$0.00	708,597	No	4	C	Direct
Common Stock, Par Value $0.001 Per Share	Acquisiton	2013-08-27	465,252	$0.00	1,173,849	No	4	C	Direct
Common Stock, Par Value $0.001 Per Share	Acquisiton	2013-08-27	48,362	$0.00	1,222,211	No	4	C	Direct
Common Stock, Par Value $0.001 Per Share	Acquisiton	2013-08-27	71,810	$4.00	1,294,021	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, Par Value $0.001 Per Share	Series B Preferred Stock	Disposition	2013-08-27	6,666,667	$0.00	399,201	$0.00
Common Stock, Par Value $0.001 Per Share	Series C Preferred Stock	Disposition	2013-08-27	4,566,908	$0.00	273,468	$0.00
Common Stock, Par Value $0.001 Per Share	Series D Preferred Stock	Disposition	2013-08-27	7,769,715	$0.00	465,252	$0.00
Common Stock, Par Value $0.001 Per Share	Series E Preferred Stock	Disposition	2013-08-27	807,652	$0.00	48,362	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct

Footnotes

The reportable securities are directly held by Quaker BioVentures, L.P. (the "Reporting Person"). Quaker BioVentures Capital, L.P. ("Quaker Capital LP") is the general partner of the Quaker. Quaker BioVentures Capital, LLC ("Quaker Capital LLC") is the general partner of Quaker Capital LP and has voting and dispositive power over the shares held by the Reporting Person. Voting and investment determinations made by Quaker Capital LLC with respect to the shares held by the Reporting Person are made by an investment committee of Quaker Partners Management, L.P., which committee includes P. Sherrill Neff, a member of the board of the directors of the Company.
The shares of Series B Preferred Stock had no expiration date and automatically converted upon the consummation of the initial public offering of Regado Biosciences, Inc. (the "Company") at a conversion ratio of 1 share of Series B Preferred Stock to 0.05988024 shares of common stock, for no additional consideration.
The shares of Series C Preferred Stock had no expiration date and automatically converted upon the consummation of the Company's initial public offering at a conversion ratio of 1 share of Series C Preferred Stock to 0.05988024 shares of common stock, for no additional consideration.
The shares of Series D Preferred Stock had no expiration date and automatically converted upon the consummation of the Company's initial public offering at a conversion ratio of 1 share of Series D Preferred Stock to 0.05988024 shares of common stock, for no additional consideration.
The shares of Series E Preferred Stock had no expiration date and automatically converted upon the consummation of the Company's initial public offering at a conversion ratio of 1 share of Series E Preferred Stock to 0.05988024 shares of common stock, for no additional consideration.